top of page

It May Not be "Just" Constipation

1 in 5 women have Obstructive Defecation Syndrome (ODS)

ODiSi™ is not currently FDA cleared for ODS. The content of the website is provided for informational purposes only.​

Click here to stay up to date. 

Women are talking about ODS

Women with ODS is a group for women to share their unique experiences in a private, positive community. Spread awareness and peace of mind by adding your voice.

Altyx has developed groundbreaking new technologies, for frequently ignored women’s pelvic health conditions including the first minimally invasive solution for female obstructed defecation.

Altyx Blog

Altyx Updates

Breakthrough Device Designation 

According to the FDA, ODiSi™, a new type of treatment for ODS, has "significant advantages over existing approved or cleared alternatives to include reducing or eliminating the need for hospitalization, improving patient quality of life, facilitating the patients’ ability to manage their own care or establishing long-term clinical efficiencies”.

Altyx Update:

National Science Foundation

SBIR Phase I & II:

National Science Foundation SBIR Phase I & II awarded for "mesh free, sling free, minimally invasive treatment for stress urinary incontinence."

Altyx Update:

New Team Member: Costas Manganiotis

Costas Manganiotis joins the Altyx Medical team as its Chief Operating Officer & President. He comes from Lexington Medical, a surgical stapling company, where he served as their Vice President and GM for international. Prior to Lexington, Costas worked for 17 years with Boston Scientific, mostly in the area of Urology & Women's health. 

bottom of page